Nicholas A. Smith

Array ( [id] => 9254834 [patent_doc_number] => 08618251 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-12-31 [patent_title] => 'Fc mutants' [patent_app_type] => utility [patent_app_number] => 12/942824 [patent_app_country] => US [patent_app_date] => 2010-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15904 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12942824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6083542 [patent_doc_number] => 20110143995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'NOVEL ANTI-ALLERGIC AGENTS' [patent_app_type] => utility [patent_app_number] => 12/942900 [patent_app_country] => US [patent_app_date] => 2010-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10843 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20110143995.pdf [firstpage_image] =>[orig_patent_app_number] => 12942900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8755242 [patent_doc_number] => 20130089546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'THERAPEUTIC NUCLEASE COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 13/505421 [patent_app_country] => US [patent_app_date] => 2010-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 34881 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5935956 [patent_doc_number] => 20110212094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/914614 [patent_app_country] => US [patent_app_date] => 2010-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 96205 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212094.pdf [firstpage_image] =>[orig_patent_app_number] => 12914614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8081023 [patent_doc_number] => 08147831 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-03 [patent_title] => 'Anti-CD19 antibodies' [patent_app_type] => utility [patent_app_number] => 12/907262 [patent_app_country] => US [patent_app_date] => 2010-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23929 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/147/08147831.pdf [firstpage_image] =>[orig_patent_app_number] => 12907262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038414 [patent_doc_number] => 20110091463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Dual Variable Domain Immunoglobulins and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/905474 [patent_app_country] => US [patent_app_date] => 2010-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 85649 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091463.pdf [firstpage_image] =>[orig_patent_app_number] => 12905474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5973594 [patent_doc_number] => 20110152504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'CD16A Binding Proteins and Use for the Treatment of Immune Disorders' [patent_app_type] => utility [patent_app_number] => 12/904554 [patent_app_country] => US [patent_app_date] => 2010-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 25512 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152504.pdf [firstpage_image] =>[orig_patent_app_number] => 12904554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6150263 [patent_doc_number] => 20110021755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'Optimized Fc Variants' [patent_app_type] => utility [patent_app_number] => 12/896610 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 92 [patent_figures_cnt] => 92 [patent_no_of_words] => 58648 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021755.pdf [firstpage_image] =>[orig_patent_app_number] => 12896610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7752010 [patent_doc_number] => 08110661 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-07 [patent_title] => 'Anti-IP-10 antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/871387 [patent_app_country] => US [patent_app_date] => 2010-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 25179 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/110/08110661.pdf [firstpage_image] =>[orig_patent_app_number] => 12871387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6125501 [patent_doc_number] => 20110086050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'GLYCOPROTEIN COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/860727 [patent_app_country] => US [patent_app_date] => 2010-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 41448 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086050.pdf [firstpage_image] =>[orig_patent_app_number] => 12860727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070130 [patent_doc_number] => 20110044980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'Dual Variable Domain Immunoglobulins and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/846317 [patent_app_country] => US [patent_app_date] => 2010-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 87641 [patent_no_of_claims] => 115 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20110044980.pdf [firstpage_image] =>[orig_patent_app_number] => 12846317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6450467 [patent_doc_number] => 20100280227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'POLYPEPTIDES THAT BIND BR3 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/835570 [patent_app_country] => US [patent_app_date] => 2010-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 73367 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20100280227.pdf [firstpage_image] =>[orig_patent_app_number] => 12835570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6195519 [patent_doc_number] => 20110027273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'IMMUNOTHERAPY OF AUTOIMMUNE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/821816 [patent_app_country] => US [patent_app_date] => 2010-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 35666 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027273.pdf [firstpage_image] =>[orig_patent_app_number] => 12821816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6270929 [patent_doc_number] => 20100255013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'GLYCOPROTEIN COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/815242 [patent_app_country] => US [patent_app_date] => 2010-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 41400 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20100255013.pdf [firstpage_image] =>[orig_patent_app_number] => 12815242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6613501 [patent_doc_number] => 20100310464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Antibodies' [patent_app_type] => utility [patent_app_number] => 12/797184 [patent_app_country] => US [patent_app_date] => 2010-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 55144 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310464.pdf [firstpage_image] =>[orig_patent_app_number] => 12797184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9995448 [patent_doc_number] => 09040041 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-26 [patent_title] => 'Modified FC molecules' [patent_app_type] => utility [patent_app_number] => 12/794560 [patent_app_country] => US [patent_app_date] => 2010-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 57 [patent_no_of_words] => 29297 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12794560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8220786 [patent_doc_number] => 20120134984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'MOLECULES WITH EXTENDED HALF-LIVES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/375002 [patent_app_country] => US [patent_app_date] => 2010-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19618 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13375002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273377 [patent_doc_number] => 08637307 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool' [patent_app_type] => utility [patent_app_number] => 12/777053 [patent_app_country] => US [patent_app_date] => 2010-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 35214 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12777053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134885 [patent_doc_number] => 20110008766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Dual Variable Domain Immunoglobulins and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/771874 [patent_app_country] => US [patent_app_date] => 2010-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 92747 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008766.pdf [firstpage_image] =>[orig_patent_app_number] => 12771874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335986 [patent_doc_number] => 20120202701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'AN ANTIBODY-GLYCAN COMPLEX TARGETING THE DISIALYL CORE II AND SIALYL LEWIS X STRUCTURES, AND USES THEREOF INVOLVING ANALYSIS OF STEM CELLS OR CANCER CELLS' [patent_app_type] => utility [patent_app_number] => 13/265953 [patent_app_country] => US [patent_app_date] => 2010-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11225 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13265953 [rel_patent_id] =>[rel_patent_doc_number] =>)